Indian CRO Eyes U.S. or EU Buyout

India’s Reliance Life Sciences (RLS) is planning an acquisition in Europe or in the U.S., joining the slow infiltration of Indian firms cementing themselves in Western markets.
Outsourcing-Pharma.com